Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Bellerophon Therapeutics Inc buy Slaandjivaa

Bellerophon Therapeutics Inc
Start price
€16.13
12.04.17 / 50%
Target price
€40.59
12.10.17
Performance (%)
38.42%
End price
€22.32
12.10.17
Summary
This prediction ended on 12.10.17 with a price of €22.32. The BUY prediction by Slaandjivaa for Bellerophon Therapeutics Inc saw massive gains of 38.42%. Slaandjivaa has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Bellerophon Therapeutics Inc - - - -
iShares Core DAX® -1.059% 5.007% 6.596% 64.713%
iShares Nasdaq 100 -2.387% 0.864% 25.791% 88.244%
iShares Nikkei 225® -4.361% 1.211% 41.309% 79.311%
iShares S&P 500 -1.778% 1.391% 21.037% 69.603%

Comments by Slaandjivaa for this prediction

In the thread Bellerophon Therapeutics Inc diskutieren
Prediction Buy
Perf. (%) 38.42%
Target price 2.706
Change
Ends at 12.10.17

Slaandjivaa stimmt der Buy-Einschätzung von datca zu

Slaandjivaa stimmt am 12.04.2017 der Buy-Einschätzung von datca mit dem Kursziel 3$ zu.
Überschrift: Bellerophon, erfolgreich tätig im Markt der Pulmonary Arterial Hypertension

Slaandjivaa 
0
Report Share
12.04.17
Prediction Buy
Perf. (%) 38.42%
Target price 2.706
Change
Ends at 12.10.17

(Laufzeit überschritten)

Slaandjivaa 
0
Report Share
12.10.17